Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−67.92 M EUR
14.29 M EUR
About EIGER BIOPHARM. DL-,0001
Sector
Industry
CEO
David Apelian
Website
Headquarters
Palo Alto
Founded
2008
FIGI
BBG005ZKCZH6
Eiger BioPharmaceuticals, Inc. operates as a biopharmaceutical company, which focuses on the development of innovative therapies for rare metabolic diseases. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia. The company was founded by David A. Cory and Glenn S. Jeffrey on November 6, 2008 and is headquartered in Palo Alto, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BER exchange EIGER BIOPHARM. DL-,0001 stocks are traded under the ticker 72C.
Yes, you can track EIGER BIOPHARM. DL-,0001 financials in yearly and quarterly reports right on TradingView.
EIGER BIOPHARM. DL-,0001 is going to release the next earnings report on May 15, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 72C doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 15, 2025, the company has 25 employees. See our rating of the largest employees — is EIGER BIOPHARM. DL-,0001 on this list?
Like other stocks, 72C shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EIGER BIOPHARM. DL-,0001 stock right from TradingView charts — choose your broker and connect to your account.